Abstract
Methadone is a potent opioid analgesic that is available in a racemic mixture of l-isomer, carrying the majority of opioid properties, and d-isomer, primarily related to NMDA receptor antagonist activity. Methadone is metabolized in the liver via CYP3A4 and, to a lesser extent, CYP2B6, CYP2D6, and CYP1A2. As a consequence this medication may have significant interactions with drugs that share the same metabolic pathway, sometimes contributing to increase of the toxic side effects of the methadone. QTc interval increase and significant sedation and respiratory depression are just a few of the devastating adverse events associated with methadone that account for the many reported deaths in recent years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gaertner J, Voltz R, Ostgathe C. Methadone: a closer look at the controversy. J Pain Symptom Manag. 2008;36(2):e4–6.
Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25:297–312.
Bruera E, Sweeney C. Methadone use in cancer patients: a review. J Palliat Med. 2002;5(1):127–38.
Ettinger DS, Vitale PJ, Trump DL. Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat Rep. 1979;63:457–9.
Garrido MJ, Aguirre C, Troconiz IF, et al. Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther. 2000;38(1):35–40.
Baumann P, Tinguely D, Schopf J. Increase of alpha 1-acid glycoprotein after treatment with amitriptyline. Br J Clin Pharmacol. 1982;14:102–3.
Sullivan HR, Smits SE, Due SL, et al. Metabolism of d-methadone: isolation and identification of analgesically active metabolites. Life Sci. 1972;11:1093–104.
Lepakhin VK. World Health Organization Web site. Safety of medicines: a guide to detecting and reporting adverse drug reactions. 2002. http://whqlibdoc.who.int/hq/2002/WHO_EDM_QSM_2002.2.pdf. Accessed 14 Nov 2015.
Shields LB, Hunsaker JC III, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci. 2007;52:1389–95.
Webster LR, Cochella S, Dasgupta N, et al. An analysis of root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12:S26–35.
Crowther NR, Holbrook AM, Kenwright R, Kenwright M. Drug interactions among commonly used medications. Can Fam Physician. 1997;43:1972–81.
Stimmel B, Lipski J, Swartz M, Donoso E. Electrocardiographic changes in heroin, methadone and multiple drug abuse: a postulated mechanism of sudden death in narcotic addicts. Proc Natl Conf Methadone Treat. 1973;1:706–10.
Krantz MJ, Lewkowiez L, et al. Torsades de Pointes with very-high-dose methadone. Ann Intern Med. 2002;137(6):501–4.
Roden DM. Drug-induced prolongation of the QT interval. NEJM. 2004;350:1013–22.
Kornick CA, Kilborn MJ, Santiago-Palma J, et al. QTc interval prolongation associated with intravenous methadone. Pain. 2003;105:499–506.
Soyka LF, Wirtz C, Spangenberg RB. Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol. 1990;65(2):74A–81A.
Chou R, Weimer MB, Dana T. Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline. J Pain. 2014;15(4):338–65.
Baxter LE Sr, Campbell A, DeShields M, et al. Safe methadone induction and stabilization. J Addict Med. 2013;7:377–86.
Perkins NA, Murphy JE, Malone DC, Armstrong EP. Performance of drug-drug interaction software for personal digital assistants. Ann Pharmacother. 2006;40(5):850–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Knoebel, R.W., Dickerson, D.M. (2018). Polypharmacy and Drug-Drug Interactions: Methadone. In: Anitescu, M., Benzon, H., Wallace, M. (eds) Challenging Cases and Complication Management in Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-60072-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-60072-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60070-3
Online ISBN: 978-3-319-60072-7
eBook Packages: MedicineMedicine (R0)